Please Wait
Applying Filters...
menu
    • menu
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Nandrolone Phenpropionate

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Pankaj Patel Owned Cadila ups its India Game with AZ’s Brands
    Pankaj Patel Owned Cadila ups its India Game with AZ’s Brands

    24 Jan 2017

    // ECONOMIC TIMES

    http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/pankaj-patel-owned-cadila-ups-its-india-game-with-azs-brands/articleshow/56734577.cms

    ECONOMIC TIMES
    24 Jan 2017
    Share Share
    Cadila Arm Acquires Six Brands from MSD Pharma
    Cadila Arm Acquires Six Brands from MSD Pharma

    04 Jan 2017

    // BIOSPECTRUM

    http://www.biospectrumasia.com/biospectrum/news/224613/cadila-arm-acquires-brands-msd-pharma

    BIOSPECTRUM
    04 Jan 2017
    Share Share
    Zydus Cadila Acquires Six Brands from Merck India
    Zydus Cadila Acquires Six Brands from Merck India

    29 Dec 2016

    // ECONOMIC TIMES

    http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/zydus-cadila-acquires-six-brands-from-msd/articleshow/56222838.cms

    ECONOMIC TIMES
    29 Dec 2016
    Share Share